为了设计更好的癌症免疫治疗点,使用-MHC-I呈现模型,HLApollo
William John Thrift1, Nicolas W Lounsbury2, Quade Broadwell1
1Early Clinical Development Artificial Intelligence, Genentech, South San Francisco, CA, USA.
Nature communications
|December 31, 2024
概括
新型变压器模型HLApollo准确地预测了个性化癌症疫苗的MHC-I呈现. 它通过分析和MHC序列来改进现有方法,帮助癌症免疫疗法开发.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 计算生物学 计算生物学
背景情况:
- 癌症免疫治疗的成功推动了对个性化癌症疫苗的需求.
- 准确预测MHC I类 (MHC-I) 上的抗原呈现对于有效的T细胞抗癌反应至关重要.
- 需要计算方法来建模-MHC-I (pMHC-I) 相互作用.
研究的目的:
- 介绍HLApollo,一种基于变压器的新型模型,用于pMHC-I呈现预测.
- 提高计算pMHC-I结合预测的准确性和范围.
- 改善个性化癌症疫苗和免疫疗法的开发.
主要方法:
- 开发了HLApollo,一种利用和MHC序列的变压器模型.
- 实现了端到端的序列处理和多元基数据的解卷.
- 在未标记的联体组数据中采用负集切换策略.
- 从蛋白质语言模型中集成的蛋白质特征.
主要成果:
- 在联结体数据上的平均精度 (AP) 提高了12.65%.
- 与现有模型相比,在免疫性测试数据上显示了4.1%的AP增加.
- 通过结合蛋白质语言模型特征,表现出更好的性能.
- 已验证的泛等位基概括,包括罕见的等位基.
结论:
- HLApollo显著提升了pMHC-I呈现预测的准确性.
- 该模型在异位基因中概括的能力对于临床应用至关重要.
- HLApollo为开发下一代个性化癌症疫苗提供了一个强大的工具.
相关概念视频
Tumor Immunotherapy
475
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
475
Cancer Vaccines
338
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
338
Antigens Involved in Adaptive Immunity
452
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
452
Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Antigen Processing Pathways
925
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
MHC Class I: Presenting Endogenous...
925


